NCT05571306

Brief Summary

Care recommendations for type 2 diabetes mellitus (T2DM) patients are clearly defined in Danish clinical guidelines: patients are offered three consultations with the general practice (GP), patients must be referred for a municipal start-up conversation, and cross-sectoral collaboration is vital to succeeding in the treatment of T2DM patients. This framework is often reported as inadequate by the patients, which increases the risk of high levels of diabetes distress (DD). Diabetes distress is the burden of living with T2DM and is associated with deleterious physical and mental health outcomes, including poor glycemic control, recurved wellbeing, and increased all-course mortality. This project evaluates the efficacy of an entry-to-care intervention, seeking to strengthen and structure the cross-sectoral collaboration, targeting DD in people recently diagnosed with T2DM. Intervention The intervention progresses throughout the first three months of the diagnosis. It is divided into core components: Improvements of cross-sectoral communication and information sharing, ensure systematism in care, guarantee participation at a "one-stop-shop" and a start-up conversation at the municipal, and improve patients coping skills. Research plan This cluster-randomized control trial is conducted in the Region of Southern Denmark, with each GP randomly assigned to intervention or control. Changes in DD are the primary outcome. Data will be collected through an electronic questionnaire at baseline and 4, 12 months after diagnosis. Perspective and expected outcomes A decrease in DD levels causes; higher level of self-care, quality of life, self-management, glycemic control and decrease the risk of severe complications and all-cause mortality. The intervention will be extrapolated to other patient groups where cross-sectoral collaboration is part of the care, increasing the treatment for these patient groups as well.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
512

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 7, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

3 years

First QC Date

September 28, 2022

Last Update Submit

June 14, 2023

Conditions

Keywords

Diabetes Distress

Outcome Measures

Primary Outcomes (1)

  • Changes in Diabetes Distress levels

    Changes in DD levels measured using the diabetes distress scale (DDS). The DDS scale was designed to measure the level of diabetes-related distress and potential contributing factors such as 'physician-related distress', 'regimen-related distress' etc..

    measured at baseline, 4, and 12 months

Secondary Outcomes (7)

  • Quality of Care reported by the patients

    measured at baseline, 4, and 12 months

  • Changes in Self-management measured by the Patient Activation Measure questionnaire

    measured at baseline, 4, and 12 months

  • Changes in the SF-12 (Quality of life)

    measured at baseline, 4, and 12 months

  • Changes in Self-care measured using the Summary of Diabetes Self-Care Activities Measurement questionnaire

    measured at baseline, 4, and 12 months

  • Changes in HbA1c

    measured at baseline, 4, and 12 months

  • +2 more secondary outcomes

Other Outcomes (4)

  • Changes in Stress scale

    measured at baseline, 4, and 12 months

  • Changes in Major Depression Inventory

    measured at baseline, 4, and 12 months

  • Changes in Social Network scale

    measured at baseline, 4, and 12 months

  • +1 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Receives a three month intervention.

Other: four core components care

Care as usual

NO INTERVENTION

This arm is given care as usual provided at a General Practice in Denmark.

Interventions

The intervention progresses throughout the first three months for the recently diagnosed T2DM patients and is divided into four core components: 1) Improve of cross-sectoral communication and information sharing, 2) ensure systematism in care, 3) guarantee participation at a "one-stop-shop" and a start-up conversation at the municipality, and 4) improve patients coping skills.

Also known as: Entry to care
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Understand Danish
  • Diagnosed according to Danish guidelines

You may not qualify if:

  • General Practitioners enrolled for the DD2 project.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Soutern Denmark

Odense C, 5000, Denmark

RECRUITING

Related Publications (14)

  • Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2017 Nov;34(11):1508-1520. doi: 10.1111/dme.13448. Epub 2017 Aug 31.

    PMID: 28799294BACKGROUND
  • Skinner TC, Joensen L, Parkin T. Twenty-five years of diabetes distress research. Diabet Med. 2020 Mar;37(3):393-400. doi: 10.1111/dme.14157. Epub 2019 Oct 31.

    PMID: 31638279BACKGROUND
  • Peimani M, Nasli-Esfahani E, Sadeghi R. Patients' perceptions of patient-provider communication and diabetes care: A systematic review of quantitative and qualitative studies. Chronic Illn. 2020 Mar;16(1):3-22. doi: 10.1177/1742395318782378. Epub 2018 Jun 12. No abstract available.

    PMID: 29895167BACKGROUND
  • Hayashino Y, Okamura S, Tsujii S, Ishii H; Diabetes Distress and Care Registry at Tenri Study Group. Association between diabetes distress and all-cause mortality in Japanese individuals with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry in Tenri [DDCRT 18]). Diabetologia. 2018 Sep;61(9):1978-1984. doi: 10.1007/s00125-018-4657-4. Epub 2018 Jun 8.

    PMID: 29947921BACKGROUND
  • Kim J, Shin W. How to do random allocation (randomization). Clin Orthop Surg. 2014 Mar;6(1):103-9. doi: 10.4055/cios.2014.6.1.103. Epub 2014 Feb 14.

    PMID: 24605197BACKGROUND
  • Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N. How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Diabet Med. 2016 Jun;33(6):835-43. doi: 10.1111/dme.12887. Epub 2015 Sep 8.

    PMID: 26287511BACKGROUND
  • Sacks RM, Greene J, Hibbard J, Overton V, Parrotta CD. Does patient activation predict the course of type 2 diabetes? A longitudinal study. Patient Educ Couns. 2017 Jul;100(7):1268-1275. doi: 10.1016/j.pec.2017.01.014. Epub 2017 Jan 25.

    PMID: 28159442BACKGROUND
  • Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33. doi: 10.1097/00005650-199603000-00003.

    PMID: 8628042BACKGROUND
  • Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul;23(7):943-50. doi: 10.2337/diacare.23.7.943.

    PMID: 10895844BACKGROUND
  • Littman AJ, White E, Satia JA, Bowen DJ, Kristal AR. Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology. 2006 Jul;17(4):398-403. doi: 10.1097/01.ede.0000219721.89552.51.

    PMID: 16641618BACKGROUND
  • Yang QQ, Sun JW, Shao D, Zhang HH, Bai CF, Cao FL. The Association between Diabetes Complications, Diabetes Distress, and Depressive Symptoms in Patients with Type 2 Diabetes Mellitus. Clin Nurs Res. 2021 Mar;30(3):293-301. doi: 10.1177/1054773820951933. Epub 2020 Aug 17.

    PMID: 32799656BACKGROUND
  • Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, Woolley T, Toobert DJ, Strycker LA, Estabrooks PA, Osuna D, Ritzwoller D. Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns. 2012 Apr;87(1):81-92. doi: 10.1016/j.pec.2011.07.024. Epub 2011 Sep 15.

    PMID: 21924576BACKGROUND
  • McCoy CE. Understanding the Intention-to-treat Principle in Randomized Controlled Trials. West J Emerg Med. 2017 Oct;18(6):1075-1078. doi: 10.5811/westjem.2017.8.35985. Epub 2017 Sep 18.

    PMID: 29085540BACKGROUND
  • Hansen SH, Jensen TM, Petersen GS, Pouwer F, Larrabee Sonderlund A, Sondergaard J. Effect of an entry-to-care intervention on diabetes distress in individuals with newly diagnosed type 2 diabetes: a study protocol for a cluster-randomized trial. Trials. 2024 Mar 21;25(1):207. doi: 10.1186/s13063-024-07949-6.

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Jens Søndergaard, Phd

    Research Unit of General Practice (University of Southern Denmark)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Steffan Holst Hansen, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Patients are blinded to what treatment their are given and the investigator and outcome Assessor is likewise blinded as each patients and general practices are annonymized..
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: As the study is a cluster randomized trial, General Practitioners are those being allocated for either intervention or control (care as usual), with controls being enrolled as late intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2022

First Posted

October 7, 2022

Study Start

January 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

June 18, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Due to legal issues this will for now not be available.

Locations